Creative Edge Nutrit Stock Today

FITX operates in the Pharmaceuticals industry. Total assets near $9.98 million highlight the size of its balance sheet, with roughly $92,278 in annual revenue. Cash reserves total roughly $1,510.
Performance
0
0100
Odds Of Distress
88
HighLow
Creative Edge presents a substantially elevated probability of financial distress, with model-implied probability near 88%. Creative Edge has delivered negative risk-adjusted returns over the past 90 trading days. The performance scores are calculated from February 5, 2026 through May 6, 2026. Learn more.
Creative Edge Nutrit cannot be verified against its exchange. It appears that Creative Edge is not available for investing at the moment. Please verify the symbol is currently traded on OTCCE Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Refresh
Creative Edge Nutrit (FITX) is listed on OTCCE Exchange in USA. FITX conducts business in the Health Care industry (Pharmaceuticals sector). Creative Edge Nutrit remains a nano-cap name by market cap, with total market value estimated at $47,479 versus health care companies. Associated fundamentals relevant to market cap include about 4.75 billion shares outstanding, operating in the Health Care industry, and enterprise value near $949,599. A negative net margin of 35.83% indicates the company is not currently profitable on a net income basis. Creative Edge is an operator in the health care segment where revenue is driven by core operating activity and end-market demand. Total debt stands at approximately $11.49 million.
Creative Edge financial stability analysis

Stock Notable Updates

Legal NameCreative Edge Nutrit
CEO and President and DirectorJames Robinson
ChairmanSam Alawieh
Chairman of the Board and Presidentident, CEOKeith Thomas
Business ConcentrationHealth Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare, (View all Sectors)

Creative Edge Nutrit Against Markets

Try Other Suggestions

FI FiservCompanyDelisted
FIP FTAI InfrastructureCompany
FITBO Fifth Third BancorpCompany
FIAWX Fidelity Advisor EquityMutual Fund
FIA Falah CapitalETF
FIL FilecoinCryptocurrency

Stock Overview, Methodology & Data Sources

Creative Edge develops and sells a portfolio of healthoriented nutrition products. Creative Edge is based in Madison Heights, Michigan. Headquarters are in 29235 Stephenson Highway, Madison Heights, MI, United States, 48071. Key reported metrics include market cap 47,479, P/S 0.01. As a micro-cap equity, Creative Edge is evaluated across valuation, solvency, and efficiency signals. Reported fundamentals are aligned with observed market behavior. More limited liquidity could contribute to wider spreads in certain market environments.

Methodology

Unless otherwise specified, financial data for Creative Edge Nutrit is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Creative Edge (USA Stocks:FITX) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. All analytics presented are generated using Macroaxis quantitative models that incorporate financial statement analysis, market data, and risk metrics to ensure consistency and comparability. Assumptions: We use public filings and market reference sources with disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR as reference inputs. Data may be normalized and can be delayed. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Creative Edge Nutrit may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.

Editorial review and methodology oversight provided by: Raphi Shpitalnik, Junior Member of Macroaxis Editorial Board

Creative Edge Corporate Executives

The leadership structure of Creative Edge Nutrit reveals who sets direction, approves budgets, and monitors management performance. A disciplined governance review can reveal strengths or weaknesses that may not be obvious in financial ratios alone.
Paul ThomasCo-Founder & Senior VPProfile

More Resources for Creative Edge Stock Analysis

Analysis of Creative Edge Nutrit often begins with its financial statements and historical patterns. The following reports provide structured context for Creative Edge Nutrit Stock: